Kyntra Bio KYNB
NASDAQ KYNB
$5.13 -0.08 (-1.54%)
As of: Oct 22, 2026 · 2:33 PM EDT

Kyntra Bio (KYNB) Non-Current Deffered Revenue (2014 - 2026)

Updated

Kyntra Bio (KYNB) reported Non-Current Deffered Revenue of $2.62 million for Q2 2026, down 97.9% from $122.22 million a year earlier and down 35.7% from the prior quarter.

Analysis

Kyntra Bio (KYNB) Non-Current Deffered Revenue (2014 - 2026) Analysis & Trends

At the end of FY2025, Kyntra Bio posted Non-Current Deffered Revenue of $255,000, down 99.8% from FY2024.

  • Non-Current Deffered Revenue has declined for four consecutive years, with a five-year compound annual growth rate of -71.6% (FY2020 to FY2025).
  • By year, Non-Current Deffered Revenue came in at $114.71 million in FY2024 (-27.2%), $157.56 million in FY2023 (-15.2%), $185.72 million in FY2022 (-0.6%) and $186.8 million in FY2021 (+34.9%).
  • Five-year quarterly Non-Current Deffered Revenue spans a low of $255,000 in Q4 2025 and a high of $205.35 million in Q2 2022.
  • Year over year, Non-Current Deffered Revenue has now declined in each of the last 15 quarters, with an average decline of 58.4% over the last eight quarters.
  • The high point for year-over-year Non-Current Deffered Revenue in five years was Q4 2021 (growth of 34.9%); the low point was Q4 2025 (a decline of 99.8%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $4.08 million (Q1 2026), $255,000 (Q4 2025) and $573,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Eli Lilly 1,167.12 Bn 1,135.70 Bn 19.71 Bn -
2 Johnson & Johnson 647.48 Bn 567.35 Bn 17.30 Bn -
3 AbbVie 502.73 Bn 475.84 Bn 12.70 Bn -
4 Merck 363.86 Bn 318.23 Bn 12.21 Bn -
5 Novartis Ag 303.31 Bn 267.30 Bn 11.24 Bn -
6 Astrazeneca 269.08 Bn 242.77 Bn 12.86 Bn -
7 Amgen 242.07 Bn 197.46 Bn 7.24 Bn -
8 Gilead Sciences 194.93 Bn 169.12 Bn 6.22 Bn -
9 Pfizer 172.42 Bn 119.07 Bn 10.94 Bn -
10 Kyntra Bio 20.69 Mn -387.26 Mn 1.47 Mn 2.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.62 Mn
Mar 31, 2026 4.08 Mn
Dec 31, 2025 255,000.00
Sep 30, 2025 573,000.00
Jun 30, 2025 122.22 Mn
Mar 31, 2025 115.35 Mn
Dec 31, 2024 114.71 Mn
Sep 30, 2024 126.22 Mn
Jun 30, 2024 131.19 Mn
Mar 31, 2024 147.12 Mn
Dec 31, 2023 157.56 Mn
Sep 30, 2023 154.21 Mn
Jun 30, 2023 165.42 Mn
Mar 31, 2023 163.09 Mn
Dec 31, 2022 185.72 Mn
Sep 30, 2022 199.76 Mn
Jun 30, 2022 205.35 Mn
Mar 31, 2022 184.89 Mn
Dec 31, 2021 186.80 Mn
Sep 30, 2021 162.42 Mn
API Access

Kyntra Bio Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=KYNB&period=max&api_key=YOUR_API_KEY